跳至主要内容
临床试验/ISRCTN30294119
ISRCTN30294119已完成未知

A pragmatic randomised controlled trial comparing the effectiveness and cost effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of Standard And New Antiepileptic Drugs (SANAD-II)

niversity of Liverpool (UK)0 个研究点目标入组 1,510 人开始时间: 2012年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,510

研究概览

简要总结

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32847927/ protocol (added 02/09/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33838757/ results for newly diagnosed focal epilepsy (added 13/04/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33838758/ results for newly diagnosed generalised and unclassifiable epilepsy (added 13/04/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34225782/ sub study on methods (added 07/07/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34931602/ HTA report (added 22/12/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male and female aged 5 years or older
  • 2. Two or more spontaneous seizures that require antiepileptic drug treatment
  • 3. Untreated and not previously treated with antiepileptic drugs
  • 4. Antiepileptic drug monotherapy considered the most appropriate option
  • 5. Willing to provide consent (patients parent/legal representative willing to give consent where the patient is aged under 16 years of age)

排除标准

  • 1. Provoked seizures (e.g. alcohol)
  • 2. Acute symptomatic seizures (e.g. acute brain haemorrhage or brain injury)
  • 3. Currently treated with antiepileptic drugs
  • 4. Progressive neurological disease (e.g. known brain tumour)

研究者

发起方
niversity of Liverpool (UK)

相似试验